Results 1 to 10 of about 9,728 (129)

Cell identity and 5-hydroxymethylcytosine [PDF]

open access: yesEpigenetics & Chromatin
Epigenetic factors underlie cellular identity through the regulation of transcriptional networks that establish a cell’s phenotype and function. Cell conversions are directed by transcription factor binding at target DNA which induce changes to identity ...
Floris Honig, Adele Murrell
doaj   +2 more sources

Increasing TET expression and 5-hydroxymethylcytosine formation by a carbocyclic 5-aza-2’-deoxy-cytidine antimetabolite

open access: yesAngewandte Chemie, EarlyView.
The carbocyclic Decitabine analog (cAzadC) incorporates as an antimetabolite weakly into the genome of growing tumor cells, where it triggers a genome‐wide demethylation and a surprisingly strong hydroxymethylation of cytosine, which translates into an efficient in vivo antitumor (AML) effect.
Däther M   +17 more
europepmc   +3 more sources

Brain 5-hydroxymethylcytosine alterations are associated with Alzheimer’s disease neuropathology [PDF]

open access: yesNature Communications
5-hydroxymethylcytosine, also known as the sixth DNA base of the genome, plays an important role in brain aging and neurological disorders such as Alzheimer’s disease.
Jinying Zhao   +18 more
doaj   +2 more sources

5‐Hydroxymethylcytosine: a new kid on the epigenetic block?

open access: yesMolecular Systems Biology, 2011
The discovery of the Ten‐Eleven‐Translocation (TET) oxygenases that catalyze the hydroxylation of 5‐methylcytosine (5mC) to 5‐hydroxymethylcytosine (5hmC) has triggered an avalanche of studies aiming to resolve the role of 5hmC in gene regulation if any.
Filomena Matarese   +1 more
exaly   +2 more sources

Genome‐Wide 5‐Methylcytosine and 5‐Hydroxymethylcytosine Signatures Analysis of Plasma Cell‐Free DNA in Schizophrenia [PDF]

open access: yesMedComm
Schizophrenia (SCZ) is a highly heritable neuropsychiatric disorder that affects ∼1% of people globally. Despite extensive research, there remains a lack of biomarkers for SCZ diagnosis and disease pathogenesis delineation.
Gang Xue   +13 more
doaj   +2 more sources

5-Hydroxymethylcytosine signatures as diagnostic biomarkers for septic cardiomyopathy [PDF]

open access: yesScientific Reports
At present, there are currently no molecular biomarkers for the early diagnosis of sepsis cardiomyopathy (SCM) in clinical practice. This study focuses on an in-depth examination of the DNA hydroxymethylation profiles within plasma extracellular vesicles
Baixin Zhen   +7 more
doaj   +2 more sources

Colorectal cancer progression to metastasis is associated with dynamic genome-wide biphasic 5-hydroxymethylcytosine accumulation [PDF]

open access: yesBMC Biology
Background Colorectal cancer (CRC) progression from adenoma to adenocarcinoma is associated with global reduction in 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). DNA hypomethylation continues upon liver metastasis.
Ben Murcott   +13 more
doaj   +2 more sources

Direct Sequencing of 5‐Methylcytosine and 5‐Hydroxymethylcytosine at Single‐Base Resolution Unravels Their Distinct Roles in Alzheimer's Disease [PDF]

open access: yesAdvanced Science
Alzheimer's disease (AD) is associated with genetic risk factors and widespread epigenetic alterations. 5‐Hydroxymethylcytosine (5hmC), an oxidized derivative of 5‐methylcytosine (5mC), constitutes up to 20% of 5mC in neuronal DNA and is implicated in ...
Zi‐Xin Wang   +15 more
doaj   +2 more sources

5-Hydroxymethylcytosine Loss in Conjunctival Melanoma

open access: yesDermatopathology, 2021
Aims: Conjunctival and cutaneous melanoma partially share similar clinical and molecular backgrounds. As 5-hydroxymethylcytosine (5-hmC) loss has been demonstrated in cutaneous melanoma, we decided to assess if similar changes were occurring in ...
Alexandre Stahl   +5 more
doaj   +1 more source

Hydroxymethylation profile of cell-free DNA is a biomarker for early colorectal cancer

open access: yesScientific Reports, 2022
Early detection of cancer will improve survival rates. The blood biomarker 5-hydroxymethylcytosine has been shown to discriminate cancer. In a large covariate-controlled study of over two thousand individual blood samples, we created, tested and explored
Nicolas J. Walker   +44 more
doaj   +1 more source

Home - About - Disclaimer - Privacy